Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

A Case of Chronic Myelogenous Leukemia with ider(22)(q10)t(9;22)(q34;q11.2) as Clonal Evolution

Kim EH, Cho HS, Lee CH, Kim KD, Hyun MS, Bae SH

  • KMID: 2239565
  • Korean J Lab Med.
  • 2003 Jun;23(3):139-142.
The ider(22)(q10)t(9;22)(q34;q11.2) is a rare secondary karyotypic aberration of Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) and was associated with disease progression and poor clinical outcomes in most of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia

Rajpal S, Nampoothiri RV, Sreedharanunni S, Parihar M, Malhotra P, Varma N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coexisting with Clonal Evolution and BCR-ABL Mutant in CML Patients Treated with Second-generation Tyrosine Kinase Inhibitors Predict the Discrepancy of in vitro Drug Sensitivity

Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ

  • KMID: 2165975
  • Cancer Res Treat.
  • 2010 Mar;42(1):37-41.
PURPOSE: Second-generation tyrosine kinase inhibitors (second TKIs) such as nilotinib and dasatinib control the activity of most ABL kinase domain mutations observed in patients with imatinib resistance. Although in vitro...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Clonal Chromosome Abnormalities in Acute Myeloid Leukemia at Diagnosis, in Remission, and in Relapse

Han JY, Kim KH, Lee YH, Kim JS, Kim HJ, Lee EY

  • KMID: 1931942
  • Korean J Clin Pathol.
  • 2000 Feb;20(1):1-6.
BACKGROUND: Approximately two thirds of acute myeloid leukemia(AML) have recognizable clonal chromosome abnormalities. We have performed the cytogenetic monitoring of 35 de novo AML to follow the karyotype changes at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A t(3;3)(q21;q26) Acute Myeloid Leukemia with the Philadelphia Chromosome as a Secondary Change

Han JY, Kim KH, Kim JS, Kim HJ, Nam R

  • KMID: 1537194
  • Korean J Hematol.
  • 2000 Feb;35(1):67-71.
The Philadelphia chromosome (Ph) appears as a secondary change at the onset of disease. However, a late-appearing or secondary Ph has also been observed in rare cases of chronic myeloid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Single-Cell Sequencing in Cancer: Recent Applications to Immunogenomics and Multi-omics Tools

Sierant MC, Choi J

Tumor heterogeneity, the cellular mosaic of multiple lineages arising from the process of clonal evolution, has continued to thwart multi-omics analyses using traditional bulk sequencing methods. The application of single-cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Aplastic Anemia

Kook H

Aplastic anemia (AA) is a rare hematopoietic stem-cell disorder that results in pancytopenia and hypocellular bone marrow. The pathophysiology of acquired AA is immune-mediated in most cases. Activated type 1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastric stem cells and gastric cancer stem cells

Han ME, Oh SO

The gastric epithelium is continuously regenerated by gastric stem cells, which give rise to various kinds of daughter cells, including parietal cells, chief cells, surface mucous cells, mucous neck cells,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Malignant Duodenal Stromal Tumor

Jeon BC, Jeong MY, Suh JI, Yang CH, Kim SC, Lee CW, Jeong BW, Kim JR, Bae HI

  • KMID: 2143764
  • Korean J Gastroenterol.
  • 1998 Jan;31(1):124-129.
Malignant stromal tumors of the small intestinal tract are uncommon and their clinical behavior is notoriously unpredictable. Gastrointestinal stromal tumors are spindle cell tumors occurring mainly in adults with 5-year...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serial Determination of FLT3-ITD and NPM1 Mutations and Its Clinical Significance in Patients with MDS at Diagnosis and After Progression to AML with Myelodysplasia-related Changes

Chung JW, Chi HS, Lee EH, Jang S, Seo EJ, Park CJ

  • KMID: 2312180
  • Lab Med Online.
  • 2011 Jul;1(3):138-146.
BACKGROUND: Accumulation of genetic aberrations in MDS is closely associated with progression to AML. FLT3-ITD is commonly found in AML and less frequently in MDS. FLT3-ITD in MDS is associated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Aplastic anemia

Kim HK

Aplastic anemia is a rare disease, which is characterized by pancytopenia and hypocellular bone marrow without infiltration of abnormal cells or fibrosis. The incidence in Asia is higher than in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Personalized cancer medicine: present status and future perspectives

Heo DS

Most cancers have oncogenes and tumor suppressor genes. First successful drug targeting a oncogene is imatinib. It was very effective for chronic myelogenous leukemia as well as gastrointestinal stromal tumors....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retrospective Analysis of Prognostic Factors Affecting Survival After Onset of Blastic Crisis of Chronic Myeloid Leukemia Especially Focused on FAB Classification

Shin HJ, Chung JS, Lee EY, Kim JS, Kim HJ, Lee WS, Sohn CH, Cho GJ

  • KMID: 2014034
  • Korean J Hematol.
  • 2003 May;38(2):119-126.
BACKGROUND: Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by a progressive course outlined by the transition from the chronic phase (CP) to blastic crisis (BC). The course...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detection of Minimal Residual Disease by IgH gene rearrangement-PCR in Childhood Acute Lymphoblastic Leukemia

Park CJ, Kim MC, Moon AR, Seo EJ, Chi HS, Seo JJ, Kim TH, Moon HN

  • KMID: 2225841
  • Korean J Clin Pathol.
  • 1999 Apr;19(2):163-171.
BACKGROUND: The IgH gene rearrangement (IgH GR) involving highly specific CDR3 region can be used as a minimal residual disease marker in ALL. The IgH GR-PCR has the advantages of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia

Kim H, Kim IS, Chang CL, Kong SY, Lim YT, Kong SG, Cho EH, Lee EY, Shin HJ, Park HJ, Eom HS, Lee H

BACKGROUND: Chromosomal abnormalities and common genetic rearrangements related to T-acute lymphoblastic leukemia (T-ALL) are not clear. We investigated T-cell receptor (TCR) rearrangement in Korean T-ALL patients by fragment analysis, examining...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease

Kim H, Seol YM, Song MK, Choi YJ, Shin HJ, Park SH, Lee EY, Chung JS

BACKGROUND: It is widely known that the prognosis of acute myeloid leukemia (AML) depends on chromosomal abnormalities. The majority of AML patients relapse and experience a dismal disease course despite...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analyses of the TCR repertoire of MHC class II-restricted innate CD4+ T cells

Kang BH, Min HS, Lee YJ, Choi B, Kim EJ, Lee J, Kim JR, Cho KH, Kim TJ, Jung KC, Park SH

Analysis of the T-cell receptor (TCR) repertoire of innate CD4+ T cells selected by major histocompatibility complex (MHC) class II-dependent thymocyte-thymocyte (T-T) interaction (T-T CD4+ T cells) is essential for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr